GABAPENTIN | A078787 | AUROBINDO PHARMA LTD
Highest NADAC/Unit
$0.0410
per ea
Lowest NADAC/Unit
$0.0210
per ea
Brand NDCs
0
Generic NDCs
14
| NDC Description | NADAC/Unit | Unit | Type | Generic NADAC | Effective |
|---|---|---|---|---|---|
| 16714066301GABAPENTIN 400 MG CAPSULE | $0.0410 | EA | Generic | — | 2026-06-17 |
| 65862020001GABAPENTIN 400 MG CAPSULE | $0.0410 | EA | Generic | — | 2026-06-17 |
| 65862020005GABAPENTIN 400 MG CAPSULE | $0.0410 | EA | Generic | — | 2026-06-17 |
| 16714066302GABAPENTIN 400 MG CAPSULE | $0.0410 | EA | Generic | — | 2026-06-17 |
| 16714066202GABAPENTIN 300 MG CAPSULE | $0.0324 | EA | Generic | — | 2026-06-17 |
| 65862019901GABAPENTIN 300 MG CAPSULE | $0.0324 | EA | Generic | — | 2026-06-17 |
Showing 6 of 14 NDCs.
Source: NADAC (data.medicaid.gov). Prices reflect national average acquisition costs for retail community pharmacies.
No patent or exclusivity listings for this strength.